Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregg J Silverman

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
Arthritis and Rheumatism|July 27, 2006
Therapeutic B cell depletion and regeneration in rheumatoid arthritis: emerging patterns and paradigmsGregg J Silverman
Nature Reviews. Immunology|June 4, 2020
Blood clots and TAM receptor signalling in COVID-19 pathogenesisGreg Lemke, Gregg J Silverman
Journal of Clinical Immunology|April 3, 2014
Natural IgM: beneficial autoantibodies for the control of inflammatory and autoimmune diseaseCaroline Grönwall, Gregg J Silverman
Arthritis and Rheumatism|June 10, 2003
Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapyGregg J Silverman, Stuart Weisman
Current Opinion in Pharmacology|July 13, 2007
B cell modulation in rheumatologyGregg J Silverman, Sahil Khanna
Experimental Cell Research|April 23, 2011
Development of anti-CD20 therapy for multiple sclerosisBeatrix Bartok, Gregg J Silverman
The Journal of Rheumatology|April 3, 2014
Rheumatoid arthritis clinical benefits from abatacept, cytokine blockers, and rituximab are all linked to modulation of memory B cell responsesGregg J Silverman, Adam Pelzek
Rheumatology and Immunology Research|December 21, 2023
Understanding the roles of the microbiome in autoimmune rheumatic diseasesAbhimanyu Amarnani, Gregg J Silverman
Immunological Reviews|July 11, 2008
Understanding the mechanistic basis in rheumatoid arthritis for clinical response to anti-CD20 therapy: the B-cell roadblock hypothesisGregg J Silverman, David L Boyle
CSH Protocols|March 2, 2011
Phage-display methodology for the study of protein-protein interactions: overviewCarl S Goodyear, Gregg J Silverman
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
Arthritis and Rheumatism|July 27, 2006
Therapeutic B cell depletion and regeneration in rheumatoid arthritis: emerging patterns and paradigmsGregg J Silverman
Nature Reviews. Immunology|June 4, 2020
Blood clots and TAM receptor signalling in COVID-19 pathogenesisGreg Lemke, Gregg J Silverman
Journal of Clinical Immunology|April 3, 2014
Natural IgM: beneficial autoantibodies for the control of inflammatory and autoimmune diseaseCaroline Grönwall, Gregg J Silverman
Arthritis and Rheumatism|June 10, 2003
Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapyGregg J Silverman, Stuart Weisman
Current Opinion in Pharmacology|July 13, 2007
B cell modulation in rheumatologyGregg J Silverman, Sahil Khanna
Experimental Cell Research|April 23, 2011
Development of anti-CD20 therapy for multiple sclerosisBeatrix Bartok, Gregg J Silverman
The Journal of Rheumatology|April 3, 2014
Rheumatoid arthritis clinical benefits from abatacept, cytokine blockers, and rituximab are all linked to modulation of memory B cell responsesGregg J Silverman, Adam Pelzek
Rheumatology and Immunology Research|December 21, 2023
Understanding the roles of the microbiome in autoimmune rheumatic diseasesAbhimanyu Amarnani, Gregg J Silverman
Immunological Reviews|July 11, 2008
Understanding the mechanistic basis in rheumatoid arthritis for clinical response to anti-CD20 therapy: the B-cell roadblock hypothesisGregg J Silverman, David L Boyle
CSH Protocols|March 2, 2011
Phage-display methodology for the study of protein-protein interactions: overviewCarl S Goodyear, Gregg J Silverman
Pageof 12